Skip to main content
. 2016 Sep 9;95(36):e4797. doi: 10.1097/MD.0000000000004797

Figure 1.

Figure 1

Kaplan–Meier survival analyses for overall survival between the NACT-IDS and PDS groups: (A) all patients; (B) NACT-IDS versus PDS; (C) platinum-resistant versus platinum-sensitive; (D) postoperative residual tumor size >1 cm versus ≤1 cm. All P values were calculated using the log-rank test. NACT-IDS = neoadjuvant chemotherapy with interval debulking surgery, PDS = primary debulking surgery.